Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
2.814
-0.056 (-1.96%)
Sep 15, 2025, 2:20 PM EDT - Market open
Galecto Market Cap
Galecto has a market cap or net worth of $3.73 million as of September 15, 2025. Its market cap has decreased by -75.32% in one year.
Market Cap
3.73M
Enterprise Value
-6.33M
1-Year Change
-75.32%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $3.73M, a decrease of -98.99%. That is a compound annual growth rate of -61.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 3.80M | -37.92% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | 368.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |